Perceptual analyses of spasmodic dysphonia before and after treatment

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 12, 2004, Pages 1393-1399

  Cannito, Michael P ^a   Woodson, Gayle E ^b   Murry, Thomas ^c   Bender, Brenda ^d  

^a UNIVERSITY OF MEMPHIS   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia University Medical School ^*  (United States)

^d ABILENE CHRISTIAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADDUCTOR SPASMODIC DYSPHONIA; ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER IMPLEMENTED VISUAL ANALOG SCALE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DYSPHONIA; FEMALE; HUMAN; MALE; MUSCLE SPASM; PERCEPTION; PERCEPTUAL ANALYSIS; PSYCHOPHYSICS; SPEECH ARTICULATION; SPEECH FLUENCY; VISUAL ANALOG SCALE; VOICE;

ADULT; AGED; AGING; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SPEECH; SPEECH PERCEPTION; TREATMENT OUTCOME; VOICE DISORDERS; VOICE QUALITY;

EID: 10044285964     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.12.1393     Document Type: Article

References (25)

1. Cannito MP, Woodson GE. The spasmodic dysphonias. In: Kent RD, Ball MJ, eds. Voice Quality Measurement. San Diego, Calif: Singular; 2000:411-430.
2. Ludlow CL. Management of the spasmodic dysphonias. In: Rubin JS, Sataloff RT, Korovin GS, Gould W, eds, Diagnosis and Treatment of Voice Disorders. New York, NY: Igaku-Shoin Medical Publishers; 1995:436-454.
3. Boutsen F, Cannito MP, Taylor M, Bender B. Botox treatment in adductor spasmodic dysphonia: a meta-analysis. J Speech Lang Hear Res. 2002;45:469-481.
4. Troung DD, Rontal M, Rolnick M, Aronson AE, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope. 1991;101(pt 1):630-634.
5. Langeveld TP, van Rossum M, Houtman EH, Zwinderman AH, Briaire JJ, Baatenburg de Jong RJ. Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment. Ann Otol Rhinol Laryngol. 2001;110(pt 1):627-634.
6. Sapienza CM, Cannito MP, Murry T, Branski R, Woodson G. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-Botox injection and within early stages of post-Botox injection. J Speech Lang Hear Res. 2002;45:830-843.
7. Ford CN, Bless DM, Patel NY. Botulinum toxin treatment of spasmodic dysphonia: techniques, indications, efficacy. J Voice. 1992;6:370-376.
8. Zwirner P, Murry T, Woodson GE. Perceptual acoustic relationships in spasmodic dysphonia. J Voice. 1993;7:165-171.
9. Adams SG, Hunt EJ, Charles DA, Lang AE. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. J Otolaryngol. 1993;22:171-175.
10. Lundy DS, Lu FL, Casiano RR, Xue JW. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia. J Voice. 1998;12:460-466.
11. Sapir S, Aronson AE, Thomas JE. Judgment of voice improvement after recurrent laryngeal nerve surgery for spastic dysphonia: clinicians versus patients. Ann Otol Rhinol Laryngol. 1986;95:137-141.
12. Langeveld TP, Drost HA, Frijns JH, Zwinderman AH, Baatenburg de Jong RJ. Perceptual characteristics of adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 2000;109(pt 1):741-748.
13. Lundy DS, Suva C, Casiano RR, Lu FL, Xue JW. Causes of hoarseness in elderly patients. Otolaryngol Head Neck Surg. 1998;118:481-485.
14. Mysak E, Duchin S. Disfluency and rate characteristics of young adult, middle aged, and elderly males. J Commun Disord. 1987;20:245-257.
15. Kreiman J, Gerratt BR, Kempster GB, Erman A, Berke GS. Perceptual evaluation of voice quality: review, tutorial, and framework for future research. J Speech Hear Res. 1993;36:21-40.
16. Aronson AE, Brown JR, Litin ME, Pearson JS. Spastic dysphonia, I: voice, neurologic, and psychiatric aspects. J Speech Hear Disord. 1968;33:203-218.
17. Cannito MP, Burch AR, Watts C, Rappold PW, Hood SB, Sherrard K. Disfluency in spasmodic dysphonia: a multivariate analysis. J Speech Lang Hear Res. 1997;40:627-641.
18. Fairbanks G. Voice and Articulation Drillbook. 2nd ed. New York, NY: Harper & Bros; 1960.
19. Liu TC, Irish JC, Adams SG, Durkin LC, Hunt EJ. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia. J Otolaryngol. 1996;25:66-74.
20. Aronson AE, McCaffrey TV, Litchey WJ, Lipton RJ. Botulinum toxin injection for adductor spasmodic dysphonia: patient self-rating of voice and phonatory effort after three successive injections. Laryngoscope. 1993;103:683-691.
21. Pearons KS, Bennett RL, Fidell S. Speech Levels in Various Noise Environments. Washington, DC: Environmental Protection Agency; 1977. Report 600/1-77-025.
22. Pool KD, Freeman FJ, Finitzo T, et al. Heterogeneity in spasmodic dysphonia: neurologic and voice findings. Arch Neurol. 1991;48:305-309.
23. Rosenfield DB. Spasmodic dysphonia. Adv Neurol. 1988;49:317-327.
24. Murry T, Woodson GE. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. J Voice. 1995;9:460-465.
25. Blitzer A, Brin MF. The dystonic larynx. J Voice. 1992;6:294-297.